rs3800779

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000238.4(KCNH2):​c.307+585G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.263 in 152,012 control chromosomes in the GnomAD database, including 5,883 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.26 ( 5883 hom., cov: 33)

Consequence

KCNH2
NM_000238.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.755

Publications

13 publications found
Variant links:
Genes affected
KCNH2 (HGNC:6251): (potassium voltage-gated channel subfamily H member 2) This gene encodes a component of a voltage-activated potassium channel found in cardiac muscle, nerve cells, and microglia. Four copies of this protein interact with one copy of the KCNE2 protein to form a functional potassium channel. Mutations in this gene can cause long QT syndrome type 2 (LQT2). Transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, May 2022]
KCNH2 Gene-Disease associations (from GenCC):
  • long QT syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • long QT syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • short QT syndrome type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: MODERATE, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.332 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000238.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNH2
NM_000238.4
MANE Select
c.307+585G>T
intron
N/ANP_000229.1A0A090N8Q0
KCNH2
NM_172056.3
c.307+585G>T
intron
N/ANP_742053.1Q12809-5
KCNH2
NM_001406755.1
c.130+585G>T
intron
N/ANP_001393684.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNH2
ENST00000262186.10
TSL:1 MANE Select
c.307+585G>T
intron
N/AENSP00000262186.5Q12809-1
KCNH2
ENST00000713710.1
c.307+585G>T
intron
N/AENSP00000519013.1A0AAQ5BGR0
KCNH2
ENST00000713701.1
c.7+244G>T
intron
N/AENSP00000519004.1A0AAQ5BGQ9

Frequencies

GnomAD3 genomes
AF:
0.263
AC:
39925
AN:
151894
Hom.:
5888
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.136
Gnomad AMI
AF:
0.344
Gnomad AMR
AF:
0.284
Gnomad ASJ
AF:
0.326
Gnomad EAS
AF:
0.105
Gnomad SAS
AF:
0.335
Gnomad FIN
AF:
0.278
Gnomad MID
AF:
0.288
Gnomad NFE
AF:
0.335
Gnomad OTH
AF:
0.269
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.263
AC:
39923
AN:
152012
Hom.:
5883
Cov.:
33
AF XY:
0.259
AC XY:
19264
AN XY:
74294
show subpopulations
African (AFR)
AF:
0.135
AC:
5612
AN:
41482
American (AMR)
AF:
0.284
AC:
4344
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.326
AC:
1132
AN:
3470
East Asian (EAS)
AF:
0.106
AC:
544
AN:
5156
South Asian (SAS)
AF:
0.335
AC:
1613
AN:
4816
European-Finnish (FIN)
AF:
0.278
AC:
2938
AN:
10568
Middle Eastern (MID)
AF:
0.279
AC:
82
AN:
294
European-Non Finnish (NFE)
AF:
0.335
AC:
22786
AN:
67932
Other (OTH)
AF:
0.265
AC:
558
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1484
2969
4453
5938
7422
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
426
852
1278
1704
2130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.273
Hom.:
2048
Bravo
AF:
0.255

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
4.9
DANN
Benign
0.75
PhyloP100
-0.76
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3800779; hg19: chr7-150671214; COSMIC: COSV51131278; API